Total Payments
$985,094
2024 Payments
$149,099
Companies
52
Transactions
1,565
Medicare Patients
11,739
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$552,678 (56.1%)
Research$136,277 (13.8%)
Consulting$130,435 (13.2%)
Travel$111,029 (11.3%)
Food & Beverage$53,448 (5.4%)
Gifts$1,126 (0.1%)
Education$100.94 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,550 | 64 | 44.4% |
| Unspecified | $136,277 | 12 | 13.8% |
| Consulting Fee | $130,435 | 63 | 13.2% |
| Travel and Lodging | $111,029 | 291 | 11.3% |
| Honoraria | $73,798 | 29 | 7.5% |
| Food and Beverage | $53,448 | 1,090 | 5.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $41,330 | 11 | 4.2% |
| Gift | $1,126 | 3 | 0.1% |
| Education | $100.94 | 2 | 0.0% |
Payments by Type
General
$848,817
1,553 transactions
Research
$136,277
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $379,438 | 240 | $0 (2024) |
| Bausch Health US, LLC | $99,798 | 5 | $0 (2019) |
| Omeros Corporation | $90,477 | 78 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $85,468 | 133 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $73,926 | 65 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $56,913 | 135 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $55,188 | 138 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $25,710 | 61 | $0 (2017) |
| Ocular Therapeutix, Inc. | $15,674 | 42 | $0 (2024) |
| Allergan, Inc. | $14,733 | 144 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149,099 | 224 | Mallinckrodt Hospital Products Inc. ($120,177) |
| 2023 | $115,174 | 199 | Mallinckrodt Hospital Products Inc. ($95,213) |
| 2022 | $153,329 | 215 | Mallinckrodt Hospital Products Inc. ($116,152) |
| 2021 | $102,032 | 209 | Mallinckrodt Hospital Products Inc. ($47,715) |
| 2020 | $57,781 | 108 | Omeros Corporation ($35,340) |
| 2019 | $250,721 | 276 | Bausch Health US, LLC ($78,294) |
| 2018 | $81,239 | 168 | Bausch Health US, LLC ($21,503) |
| 2017 | $75,719 | 166 | Sun Pharmaceutical Industries Inc. ($43,215) |
All Payment Transactions
1,565 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Consulting Fee | Cash or cash equivalent | $8,500.00 | General |
| Category: Ophthalmology | ||||||
| 12/19/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $179.00 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: EYE CARE | ||||||
| 12/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $77.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $67.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: EYE CARE | ||||||
| 12/08/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $464.96 | General |
| Category: Ophthalmology | ||||||
| 12/08/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $129.20 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $50.75 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $149.20 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $114.40 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: EYE CARE | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,770.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BAUSCH & LOMB OVD DISPERSIVE DVISC40 STUDY S877 | Bausch Health US, LLC | $78,294 | 3 |
| A STUDY TO DOCUMENT THE SAFETY AND EFFECTIVENESS OF A NEW OPHTHALMIC VISCOSURGICAL DEVICE OVD WHEN COMPARED TO A CONTROL OVD | Bausch Health US, LLC | $21,493 | 1 |
| A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment | Allergan Inc. | $1,150 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,067 | 3,688 | $1.3M | $359,912 |
| 2022 | 21 | 2,571 | 3,041 | $1.2M | $316,782 |
| 2021 | 30 | 3,010 | 3,766 | $1.6M | $440,267 |
| 2020 | 27 | 3,091 | 3,910 | $1.5M | $438,644 |
Total Patients
11,739
Total Services
14,405
Medicare Billing
$1.6M
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 166 | 244 | $392,574 | $100,851 | 25.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 233 | 320 | $276,334 | $76,508 | 27.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 751 | 879 | $226,233 | $74,266 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 251 | $76,277 | $21,480 | 28.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 423 | 480 | $63,334 | $19,391 | 30.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 153 | 213 | $40,596 | $13,341 | 32.9% |
| 92134 | Imaging of retina | Office | 2023 | 238 | 352 | $30,359 | $10,081 | 33.2% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 11 | 12 | $20,494 | $6,957 | 33.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 280 | 293 | $22,261 | $6,698 | 30.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 68 | 68 | $20,630 | $5,978 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $18,678 | $5,252 | 28.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 145 | 159 | $16,260 | $5,060 | 31.1% |
| 92250 | Photography of the retina | Office | 2023 | 215 | 217 | $17,335 | $4,709 | 27.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 22 | 52 | $13,429 | $4,475 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 33 | $6,813 | $2,273 | 33.4% |
| 66030 | Injection of medication into eye | Facility | 2023 | 12 | 23 | $8,968 | $1,984 | 22.1% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 13 | 13 | $925.00 | $278.78 | 30.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 12 | 12 | $762.00 | $217.10 | 28.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 13 | 13 | $325.00 | $111.14 | 34.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 167 | 247 | $487,820 | $101,083 | 20.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 741 | 874 | $153,374 | $70,826 | 46.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 154 | 212 | $199,072 | $49,008 | 24.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 182 | 257 | $29,922 | $15,830 | 52.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 326 | 371 | $47,355 | $15,008 | 31.7% |
| 66174 | Dilation to improve eye fluid flow | Facility | 2022 | 20 | 24 | $47,848 | $13,650 | 28.5% |
About Dr. Steven Silverstein, MD
Dr. Steven Silverstein, MD is a Ophthalmology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285622951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Silverstein, MD has received a total of $985,094 in payments from pharmaceutical and medical device companies, with $149,099 received in 2024. These payments were reported across 1,565 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($437,550).
As a Medicare-enrolled provider, Silverstein has provided services to 11,739 Medicare beneficiaries, totaling 14,405 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Kansas City, MO
- Active Since 10/07/2005
- Last Updated 07/11/2014
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1285622951
Products in Payments
- ACTHAR (Biological) $453,364
- DVISC40 (Device) $78,294
- STELLARIS ELITE (Device) $49,669
- Omidria (Drug) $46,969
- OMIDRIA (Drug) $43,564
- Bromsite (Drug) $43,215
- STELLARIS PC (Device) $43,203
- BROMSITE (Drug) $21,182
- STELLARIS (Device) $17,994
- DEXTENZA (Drug) $15,192
- Cequa (Drug) $11,651
- EYSUVIS (Drug) $9,937
- DEXYCU (Drug) $9,656
- PROLENSA (Drug) $7,025
- Humphrey HFA (Device) $7,000
- XIIDRA (Drug) $6,579
- CEQUA (Drug) $6,377
- ALREX (Drug) $5,324
- TEPEZZA (Drug) $4,300
- COMBIGAN (Drug) $4,039
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Kansas City
Dr. Joseph Tauber, M.d, M.D
Ophthalmology — Payments: $270,535
Ophthalmology $270,535
Stephen Wiles, Md, MD
Ophthalmology — Payments: $11,692
Ophthalmology $11,692
Abraham Park, Md, MD
Ophthalmology — Payments: $11,594
Ophthalmology $11,594
Dr. Michelle Boyce, Md, MD
Ophthalmology — Payments: $9,434
Ophthalmology $9,434
Dr. Lindsey Mcdaniel, M.d, M.D
Ophthalmology — Payments: $5,304
Ophthalmology $5,304
Michael Cassell, M.d, M.D
Ophthalmology — Payments: $5,006
Ophthalmology $5,006